Literature DB >> 10087390

Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping.

L Salomon1, M Colombel, J J Patard, M A Lefrère-Belda, J Bellot, D Chopin, C C Abbou.   

Abstract

OBJECTIVE: To determine the value of positive sextant biopsies in assessing the location of prostate tumors within radical prostatectomy specimens and to determine if prostate weight influences the results.
METHODS: From 1988 to 1996, 166 radical prostatectomies were performed for localized prostate cancer diagnosed by means of ultrasound-guided sextant biopsies. The location of the biopsies was compared with that of tumor tissue within the radical prostatectomy specimen.
RESULTS: Of the 996 biopsies, 331 (33%) were positive. The correspondence between the location of the biopsies and that of tumor tissue in the surgical specimen was found to have a sensitivity of 39.4%, a specificity of 81.5%, a positive predictive value of 83.3%, negative predictive value of 36.4% and an accuracy of 52%. For prostates weighing < and >/= 45 g, the sensitivity was 39.9 and 38.9%, the specificity was 88 and 77.2%, the positive predictive value was 90.8 and 76.1%, the negative predictive value was 34.9 and 39.8%, and the accuracy was 52 and 52%, respectively.
CONCLUSION: Negative biopsies do not predict a lack of tumor tissue in the corresponding prostate site after radical prostatectomy, and had less value than positive biopsies for prognostic staging before radical prostatectomy. Results of sextant biopsies are more significant for prognosis before radical prostatectomy when positive. Prostate weight influences the interpretation of the results of sextant biopsies.

Entities:  

Mesh:

Year:  1999        PMID: 10087390     DOI: 10.1159/000019863

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

Review 1.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

2.  Endorectal MRI after radiation therapy: questioning the sextant analysis.

Authors:  Shilpa R Kumbhani; Fergus V Coakley; Charles E McCulloch; Z Jane Wang; John Kurhanewicz; Mack Roach; Antonio C Westphalen
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

Review 3.  Advancements in magnetic resonance-guided robotic interventions in the prostate.

Authors:  Katarzyna J Macura; Dan Stoianovici
Journal:  Top Magn Reson Imaging       Date:  2008-12

4.  T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging.

Authors:  Tsutomu Tamada; Teruki Sone; Kiyohisa Nagai; Yoshimasa Jo; Masayuki Gyoten; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2003-10-18       Impact factor: 5.315

5.  Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.

Authors:  Tim Joseph; David A McKenna; Antonio C Westphalen; Fergus V Coakley; Shoujun Zhao; Ying Lu; I-Chow Hsu; Mack Roach; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-28       Impact factor: 7.038

6.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

Authors:  Jeffrey C Weinreb; Jeffrey D Blume; Fergus V Coakley; Thomas M Wheeler; Jean B Cormack; Christopher K Sotto; Haesun Cho; Akira Kawashima; Clare M Tempany-Afdhal; Katarzyna J Macura; Mark Rosen; Scott R Gerst; John Kurhanewicz
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

7.  The characteristics and spatial distributions of initially missed and rebiopsy-detected prostate cancers.

Authors:  Myung-Won You; Mi-Hyun Kim; Jeong Kon Kim; Kyoung-Sik Cho
Journal:  Ultrasonography       Date:  2016-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.